4.8 Article

RNA mis-splicing drives viral mimicry response after DNMTi therapy in SETD2-mutant kidney cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

Bastien Nguyen et al.

Summary: This study investigates the genomic mechanisms driving metastasis in cancer patients. By analyzing a cohort of over 25,000 patients with metastatic diseases, the researchers identify associations between genomic alterations and patterns of metastatic dissemination across different tumor types. The study highlights the complex role of chromosomal instability in cancer progression and provides valuable insights for further research on metastatic spread.
Review Biochemistry & Molecular Biology

Transposable element regulation and expression in cancer

Erin E. Grundy et al.

Summary: Approximately 45% of the human genome is composed of transposable elements (TEs), which are tightly regulated during normal development. During the transformation from normal to cancer, TEs can lose epigenetic silencing and become transcribed, sometimes becoming active.

FEBS JOURNAL (2022)

Article Biochemistry & Molecular Biology

FBXO44 promotes DNA replication-coupled repetitive element silencing in cancer cells

Jia Z. Shen et al.

Summary: The study identified FBXO44 as an essential repressor of repetitive elements in cancer cells, with its inhibition leading to DNA replication stress and viral mimicry. This promotes decreased tumorigenicity, increased immunogenicity, and enhanced immunotherapy response in cancer cells.
Article Biochemistry & Molecular Biology

Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer

Elizabeth A. Bowling et al.

Summary: This study reveals that mis-spliced RNA can trigger tumor cell death through viral mimicry, where dsRNA-binding proteins recognize mis-spliced RNA and induce antiviral signaling and apoptosis. Additionally, the findings suggest that STTs may activate anti-tumor immune pathways by responding to global aberrations of RNA splicing in cancer.
Article Oncology

Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

Lewis Au et al.

Summary: The ADAPTeR study aimed to investigate the mechanism of therapeutic response to nivolumab in metastatic clear cell renal cell carcinoma, with genomic analysis showing no correlation between tumor molecular features and response. Pre-existing immunity may play a key role in predicting clinical response.

CANCER CELL (2021)

Article Multidisciplinary Sciences

The methyltransferase SETD2 couples transcription and splicing by engaging mRNA processing factors through its SHI domain

Saikat Bhattacharya et al.

Summary: The study reveals that the histone methyltransferase SETD2 interacts with hnRNP L to regulate a subset of hnRNP L-targeted AS events, mediating crosstalk between the transcription and splicing machineries.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Structural basis of the interaction between SETD2 methyltransferase and hnRNP L paralogs for governing co-transcriptional splicing

Saikat Bhattacharya et al.

Summary: The paper describes the interaction between hnRNP L and SETD2, revealing their binding mechanism. The study demonstrates that a leucine pair in SETD2 inserts their side chains in hydrophobic pockets formed by hnRNP L RRM2 for interaction to occur, highlighting the importance of this binding interaction. The similarity in the mode of SETD2-hnRNP L interaction with other related protein-protein interactions suggests a conserved design for splicing regulators to interact with one another.

NATURE COMMUNICATIONS (2021)

Article Oncology

Prognostic Impact of Loss of SETD2 in Clear Cell Renal Cell Carcinoma

Victor Espinheira Santos et al.

Summary: The study demonstrated that negative expression of SETD2 was associated with a worse prognosis in patients with clear cell renal cell carcinoma, and it was an independent predictor of survival. The protein expression of SETD2 is an important biomarker in the management of patients with ccRCC.

CLINICAL GENITOURINARY CANCER (2021)

Review Immunology

MDSC: Markers, development, states, and unaddressed complexity

Samarth Hegde et al.

Summary: MDSCs are a widely discussed biological entity in immunology, commonly describing cells that arise during chronic inflammation with T cell immunosuppressive functions. Currently lacking clear definitions and a unifying framework across pathologies, we propose a framework based on activation signals to classify MDSCs as discrete cell states. Developing this knowledge of myeloid states across pathological conditions may transform how diseases are grouped and treated.

IMMUNITY (2021)

Article Biochemistry & Molecular Biology

Pharmacologic modulation of RNA splicing enhances anti-tumor immunity

Sydney X. Lu et al.

Summary: The study demonstrates that modulation of splicing through specific drug classes generates genuine neoantigens and enhances anti-tumor immunity, augmenting checkpoint immunotherapy.
Review Biotechnology & Applied Microbiology

Endogenous retroviruses in the origins and treatment of cancer

Natasha Jansz et al.

Summary: Endogenous retroviruses (ERVs) are emerging as promising therapeutic targets in cancer, coordinating gene expression networks and promoting interferon responses. Despite being associated with cancer, autoimmune, and neurodegenerative diseases, harnessing ERV-mediated inflammation may sensitize tumors to immunotherapy.

GENOME BIOLOGY (2021)

Article Cell Biology

SETD2 mutation in renal clear cell carcinoma suppress autophagy via regulation of ATG12

Patricia Gonzalez-Rodriguez et al.

CELL DEATH & DISEASE (2020)

Review Urology & Nephrology

Genomic profiling in renal cell carcinoma

Nazli Dizman et al.

NATURE REVIEWS NEPHROLOGY (2020)

Article Multidisciplinary Sciences

Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency

Parinaz Mehdipour et al.

NATURE (2020)

Article Multidisciplinary Sciences

The HUSH complex is a gatekeeper of type I interferon through epigenetic regulation of LINE-1s

Hale Tunbak et al.

NATURE COMMUNICATIONS (2020)

Review Biochemistry & Molecular Biology

Roles of SETD2 in LeukemiaTranscription, DNA-Damage, and Beyond

Anna Skucha et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Genetics & Heredity

SETD2 regulates the maternal epigenome, genomic imprinting and embryonic development

Qianhua Xu et al.

NATURE GENETICS (2019)

Article Biochemistry & Molecular Biology

WashU Epigenome Browser update 2019

Daofeng Li et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Biotechnology & Applied Microbiology

Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype

Daehwan Kim et al.

NATURE BIOTECHNOLOGY (2019)

Review Oncology

Epigenetic therapy in immune-oncology

Peter A. Jones et al.

NATURE REVIEWS CANCER (2019)

Article Biochemistry & Molecular Biology

Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal

Samra Turajlic et al.

Article Biochemistry & Molecular Biology

Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal

Samra Turajlic et al.

Article Biochemistry & Molecular Biology

Switching roles for DNA and histone methylation depend on evolutionary ages of human endogenous retroviruses

Hitoshi Ohtani et al.

GENOME RESEARCH (2018)

Review Urology & Nephrology

Epigenetic modifiers: activities in renal cell carcinoma

Aguirre A. de Cubas et al.

NATURE REVIEWS UROLOGY (2018)

Article Cell Biology

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

Christopher J. Ricketts et al.

CELL REPORTS (2018)

Article Biochemical Research Methods

ggsashimi: Sashimi plot revised for browser- and annotation-independent splicing visualization

Diego Garrido-Martin et al.

PLOS COMPUTATIONAL BIOLOGY (2018)

Article Medicine, Research & Experimental

Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma

Christof C. Smith et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Article Biochemical Research Methods

Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi

Jean-Philippe Fortin et al.

BIOINFORMATICS (2017)

Article Medicine, Research & Experimental

Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis

Huairui Yuan et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Article Multidisciplinary Sciences

Intragenic DNA methylation prevents spurious transcription initiation

Francesco Neri et al.

NATURE (2017)

Article Biochemical Research Methods

Strawberry: Fast and accurate genome-guided transcript reconstruction and quantification from RNA-Seq

Ruolin Liu et al.

PLOS COMPUTATIONAL BIOLOGY (2017)

Article Gastroenterology & Hepatology

SETD2 histone modifier loss in aggressive GI stromal tumours

Kie Kyon Huang et al.

Article Biochemistry & Molecular Biology

Dual Chromatin and Cytoskeletal Remodeling by SETD2

In Young Park et al.

Review Genetics & Heredity

Targeting the cancer epigenome for therapy

Peter A. Jones et al.

NATURE REVIEWS GENETICS (2016)

Article Biochemistry & Molecular Biology

deepTools2: a next generation web server for deep-sequencing data analysis

Fidel Ramirez et al.

NUCLEIC ACIDS RESEARCH (2016)

Article Multidisciplinary Sciences

Vitamin C increases viral mimicry induced by 5-aza-2′-deoxycytidine

Minmin Liu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Multidisciplinary Sciences

DNMT3B isoforms without catalytic activity stimulate gene body methylation as accessory proteins in somatic cells

Christopher E. Duymich et al.

NATURE COMMUNICATIONS (2016)

Article Multidisciplinary Sciences

Isoform switching and exon skipping induced by the DNA methylation inhibitor 5-Aza-2′-deoxycytidine

Xiao-Lei Ding et al.

SCIENTIFIC REPORTS (2016)

Article Biochemistry & Molecular Biology

Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses

Katherine B. Chiappinelli et al.

Article Biotechnology & Applied Microbiology

StringTie enables improved reconstruction of a transcriptome from RNA-seq reads

Mihaela Pertea et al.

NATURE BIOTECHNOLOGY (2015)

Article Urology & Nephrology

Landmarks in the diagnosis and treatment of renal cell carcinoma

Jaimin R. Bhatt et al.

NATURE REVIEWS UROLOGY (2014)

Article Multidisciplinary Sciences

Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells

Ophir Shalem et al.

SCIENCE (2014)

Article Oncology

Targeted Delivery of Paclitaxel to EphA2-Expressing Cancer Cells

Si Wang et al.

CLINICAL CANCER RESEARCH (2013)

Article Biochemistry & Molecular Biology

Histone H3 lysine 9 trimethylation and HP1γ favor inclusion of alternative exons

Violaine Saint-Andre et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)

Article Biochemistry & Molecular Biology

Splicing enhances recruitment of methyltransferase HYPB/Setd2 and methylation of histone H3 Lys36

Sergio Fernandes de Almeida et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)

Review Oncology

A decade of exploring the cancer epigenome - biological and translational implications

Stephen B. Baylin et al.

NATURE REVIEWS CANCER (2011)

Article Biochemical Research Methods

BEDTools: a flexible suite of utilities for comparing genomic features

Aaron R. Quinlan et al.

BIOINFORMATICS (2010)

Review Oncology

Epigenetics in cancer

Shikhar Sharma et al.

CARCINOGENESIS (2010)

Article Multidisciplinary Sciences

Regulation of Alternative Splicing by Histone Modifications

Reini F. Luco et al.

SCIENCE (2010)

Article Genetics & Heredity

Differential chromatin marking of introns and expressed exons by H3K36me3

Paulina Kolasinska-Zwierz et al.

NATURE GENETICS (2009)